Antares Pharma

We at Antares Pharma leverage our pharmaceutical and medical device expertise to develop innovative products that address needs in underserved therapeutic areas.

Our relentless pursuit of better therapies that positively affect patient lives inspires our employees to serve our customers and stakeholders every day.

Stock
Information

Antares Pharma is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Antares Pharma performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Antares Pharma, Inc. or its management. Antares Pharma, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

  Firm Analyst  
Cowen-icon.png Cowen and Company Ken Cacciatore  
HCW-icon.png H.C. Wainwright Oren Livnat  
Jefferies-icon.png Jefferies Anthony Petrone  
LThalman-icon.png Ladenburg Thalmann Matthew L. Kaplan  
Piper-Jaffray-icon.png Piper Sandler David Amsellem  
RJ-icon.jpg Raymond James Elliot Wilbur  
Truist-icon.png Truist Gregory Fraser  

ATRS

Price: $3.3
Change: -$-0.12 (--3.51%)
Quotes delayed at least 15 minutes